QA: Biostax Corp in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001559356_2022_Biostax_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0001559356, Biostax Corp

  xvar xval
0 AssetsCurrent 3,138,885
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 11,087,141
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 585,502
9 ResearchAndDevelopmentExpense 152,667
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 3,138,885
1 Liabilities 11,087,141
2 Expenses 738,169
3 Revenues 0
4 StockholdersEquity -7,948,256
5 NetIncome -738,169
6 ComprehensiveNetIncome -738,169
7 BaseVar 7,482,098
8 EconomicCapitalRatiobeforeLimitedLiability -2.54
9 EconomicCapitalRatio 0.842

Edgar->Model Mapping

Feature Distribution